## BRK-B: Berkshire Hathaway Inc. New - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -3.5% below STRENGTH zone (4.0-10.0%); PEG 10.06 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($482.89)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($54.35M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.2% (+0.8%)
- Blackrock Inc.: 8.4% (+1.0%)
- State Street Corpora: 5.3% (+0.5%)
- Geode Capital Manage: 2.9% (+0.2%)
- Morgan Stanley: 1.9% (-2.3%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.5% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $54M sold (6 transactions in 90 days).
3. Valuation stretched: PEG 10.1x requires aggressive growth execution.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 10.06 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 18%). Balance sheet: strong liquidity (48.7x), $8.2B free cash flow. Insider selling cluster ($54.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1072.7B |
| Beta | 0.70 |
| 52W Range | $440.10 - $542.07 |
| Short Interest | 1.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 10.06 |
| Forward P/E | 20.6 |
| Current P/E | 23.4 |
| YoY Growth | 13.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.0% to -3.5% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). Underperforming sector by 3.0pp, stock-specific weakness. Below SMA200 (1.00x), long-term trend not supportive. MACD histogram bearish (-1.21), momentum weakening. RSI neutral at 45.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.53% (CS: 28) | Weak |
| RSI_14 | 45.0 | Neutral |
| MACD Histogram | -1.21 | Bearish |
| vs SMA20 | 0.985x | Below |
| vs SMA50 | 1.000x | Below |
| vs SMA200 | 0.998x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $497.23
- **Stop Loss:** $482.89 (2.9% risk)
- **Target:** $511.57 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 69
- **Position Value:** $34,308.87
- **Portfolio %:** 34.31%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-21 (Est: $5.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.73 | $6.25 | +9.0% |
| 2025Q2 | $5.04 | $5.17 | +2.7% |
| 2025Q1 | $4.72 | $4.47 | -5.4% |
| 2024Q4 | $4.19 | $6.73 | +60.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*